Essentia Health rolls out promising Alzheimer’s disease detection method

44 seconds ago Emily Halling , Adam Jagunich ,

DULUTH, Minn.– After nearly one hundred years of research, a recent break through with Alzheimer’s disease has already seen success in the Northland.

The innovation involves an injectable radio pharmaceutical called “Amyvid.”

It is injected shortly before the patient has a routine PET or CT scan.

Before Duluth invested in this, patients near and far had to travel to the Twin Cities for this opportunity.

And with this new tech, it targets and detects amyloid plaques. A protein built up in patients’ brains.

One of the neurologists told FOX 21, that 1 in 9 people will be diagnosed with Alzheimer’s after the age of 65.

And before this opportunity, treatment for the disease was grim.

“Recently as about two years ago, we would just